TITLE

Prevalence of hepatitis B and C markers in high-risk hospitalised patients in Crete: a five-year observational study

AUTHOR(S)
Koulentaki, Meri; Ergazaki, Maria; Moschandrea, Joanna; Spanoudakis, Stelios; Tzagarakis, Nikolaos; Drandakis, Pandelis E.; Spandidos, Dimitrios A.; Kouroumalis, Elias A.
PUB. DATE
January 2001
SOURCE
BMC Public Health;2001, Vol. 1 Issue 1, p17
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: So far the prevalence of viral hepatitis infection in hospitalized patients has not been extensively studied. Therefore we conducted the present five-year observational study to evaluate the prevalence of HBV and HCV infection in high-risk hospitalized patients of Crete, the largest Greek island, Due to the homogeneous population, epidemiological studies can be accurately done. Methods: The study was carried out in two out of four District General Hospitals, and in the University Hospital of the island. Markers for HBV and HCV were studied and statistically evaluated according to age, sex and geographical area, in a well-defined hospitalized population. Results: The total prevalence of HBsAg and anti-HCV in the three prefectures during the five-year study is 2.66% and 4.75% respectively. Overall the relative risks were higher in males than females for each hepatitis marker (p < 0.001). Higher prevalence of HBcAb was found in the 41-60 years age group for both sexes (males 36.17%, females 27.38%). Peak HBsAg prevalence was found in the age group of 21-40 and 41-60 years for males (5.4%) and females (3.09%) respectively. Anti-HCV prevalence increases with age reaching the highest prevalence in the age group of 41-60 years for males (7.19%) and in the 61-90 years age group for females (7.16%). For both sexes significant differences between the three locations were identified. For HBsAg a higher prevalence in Heraklion (3.96%) compared to Chania (2.30%, males: p < 0.0001, females: p < 0.05) and Rethymnon (1.45%, males: p < 0.01, females: p < 0.0001) was detected. For HCV a significantly higher prevalence in Heraklion (6.54%) compared to Chania (2.39%, males: p < 0.001, females: p < 0.001) but not in Rethymnon (5.15%, NS). A lower prevalence rate of HBcAb in Heraklion compared to Chania (20.07% versus 23.05%, males: p < 0.001, females: p < 0.001) was found. Conclusions: These results were possibly overestimated, but nevertheless reflect the situation of the general population within the island as shown by our previous publications in other study groups. Moreover they contribute to the mapping of viral hepatitis prevalence in a geographical area of Southern Europe and may be helpful in planning public health interventional strategies.
ACCESSION #
29336457

 

Related Articles

  • Alcoholism is Associated with Hepatitis C but not Hepatitis B in an Urban Population. Rosman, Alan S.; Waraich, Afsar; Galvin, Kathryn; Casiano, Joanne; Paronetto, Fiorenzo; Lieber, Charles S. // American Journal of Gastroenterology;Mar1996, Vol. 91 Issue 3, p498 

    Objectives: Previous studies have suggested an association of viral hepatitis with alcoholism, although the role of confounding risk factors (e.g., i.v. drug use) has not been adequately excluded. We therefore compared the seroprevalences of hepatitis B and C in alcoholic patients to...

  • Advances in the Treatment of Chronic Viral Hepatitis. Koff, Raymond S. // JAMA: Journal of the American Medical Association;8/11/99, Vol. 282 Issue 6, p511 

    Discusses chronic viral hepatitis. Its position as the predominant chronic liver disease in the United States; Viruses responsible for the disease; Statistics related to the disease; Methods of diagnosis and treatment; Comparison of hepatitis C and hepatitis B & D; Future prospects.

  • Chronic viral hepatitis B and C: What you need to know in 1995.  // Modern Medicine;Apr95, Vol. 63 Issue 4, p29 

    Presents Willis C. Maddrey's tips for the treatment of chronic viral hepatitis B and C. Chronicity of hepatitis C; Use of interferon alfa-2b in treating hepatitis; Use of ursodiol for treatment failures; Antigens associated with hepatitis.

  • Seroprevalence of hepatitis B and C virus infections: Results from the 2007 to 2009 and 2009 to 2011 Canadian Health Measures Survey. Rotermann, Michelle; Langlois, Kellie; Andonov, Anton; Trubnikov, Maxim // Health Reports;Nov2013, Vol. 24 Issue 11, p3 

    Background Chronic hepatitis B (HBV) and C (HCV) virus infections can lead to liver failure, liver cancer, and death. In Canada, prevalence studies of HBV and HCV have been limited to regional and special populations. Data and methods Data are from cycles 1 (2007 to 2009) and 2 (2009 to 2011) of...

  • The role of serum Th1 and Th2 cytokines in patients with chronic hepatitis B and hepatitis C virus infection. Priimägi, Ljudmilla; Tefanova, Valentina; Tallo, Tatjana; Schmidt, Elena // Acta Medica Lituanica;2005, Vol. 12 Issue 3, p28 

    Background. The imbalance of pro-inflammatory Th1 and anti-inflammatory Th2 cytokine production may play an important role in the immunopathogenesis of hepatitis B and C virus infection. The aim of this study was to analyze serum levels of Th1 and Th2 cytokines in patients with chronic hepatitis...

  • Effects of Metabolic Syndrome on Fibrosis in Chronic Viral Hepatitis. Harry Yoon; Jeong Guil Lee; Jeong Hwan Yoo; Myung Su Son; Dae Young Kim; Seong Gyu Hwang; Kyu Sung Rim // Gut & Liver;Jul2013, Vol. 7 Issue 4, p469 

    Background/Aims: Metabolic syndrome, comprising diabetes, hypertension, central obesity, and dyslipidemia, is increasingly prevalent worldwide. We aimed to study the relationship between metabolic syndrome and the risk of liver fibrosis in patients with chronic hepatitis B (CHB) and chronic...

  • Shot of reality. Rybka, Ted // Echo Magazine;3/24/2005, Vol. 16 Issue 14, p54 

    Emphasizes the significance of hepatitis vaccination in the U.S. Lack of vaccine against hepatitis C; Rate of hepatitis infection among men who have sex with men; Mode of transmission and symptoms of hepatitis A, B and C.

  • Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver. Aydeniz, Ali; Namiduru, M.; Karaoglan, I.; Altindag, O.; Yagiz, E.; Gursoy, S. // Rheumatology International;Feb2010, Vol. 30 Issue 4, p515 

    The objective of this study is to investigate rheumatologic manifestations of hepatitis B and C and their relation with viral load and degree of hepatic fibrosis. Thirty-six HBV and 36 HBV patients were included. Liver biopsy was performed for all participants. We detected arthralgia...

  • Completeness of Reporting of Chronic Hepatitis B and C Virus Infections -- Michigan, 1995-2008. Kirkey, Kim; MacMaster, Karen; Suryaprasad, Anil; Fujie Xu; Klevens, Monina; Roberts, Henry; Moorman, Anne; Holmberg, Scott; Webeck, Jenna // MMWR: Morbidity & Mortality Weekly Report;2/15/2013, Vol. 62 Issue 6, p99 

    The article examines the completeness of reporting of chronic hepatitis B and C virus infections in Michigan from 1995 to 2008. It cites pieces of evidence of underreporting of the illnesses in the U.S. based on a comprehensive evaluation of national viral hepatitis surveillance. It also...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics